{"organizations": [], "uuid": "a9de4c8767e09483f4260b38d27246ceb3bb0828", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-west-pharmaceutical-reports-q4-adj/brief-west-pharmaceutical-reports-q4-adjusted-earnings-per-share-0-64-idUSASB0C5W3", "country": "US", "domain_rank": 408, "title": "BRIEF-West Pharmaceutical Reports Q4 Adjusted Earnings Per Share $0.64", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T13:15:00.000+02:00", "replies_count": 0, "uuid": "a9de4c8767e09483f4260b38d27246ceb3bb0828"}, "author": "", "url": "https://www.reuters.com/article/brief-west-pharmaceutical-reports-q4-adj/brief-west-pharmaceutical-reports-q4-adjusted-earnings-per-share-0-64-idUSASB0C5W3", "ord_in_thread": 0, "title": "BRIEF-West Pharmaceutical Reports Q4 Adjusted Earnings Per Share $0.64", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - west pharmaceutical services inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 18 AM / Updated 6 minutes ago BRIEF-West Pharmaceutical Reports Q4 Adjusted Earnings Per Share $0.64 Reuters Staff Feb 15 (Reuters) - West Pharmaceutical Services Inc: * WEST ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS AND ANNOUNCES QUARTERLY DIVIDEND * SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.80 TO $2.90 * Q4 EARNINGS PER SHARE $0.00 * Q4 SALES ROSE 8.7 PERCENT TO $415.6 MILLION * Q4 ADJUSTED EARNINGS PER SHARE $0.64 EXCLUDING ITEMS * SEES FY 2018 SALES $1.72 BILLION TO $1.73 BILLION * BOARD HAS APPROVED A RESTRUCTURING PROGRAM * WEST PHARMACEUTICAL SERVICES - RESTRUCTURING PLAN WILL REQUIRE RESTRUCTURING EXPENSE OF $8.0 MILLION TO $13.0 MILLION * ‍COMPANY ESTIMATES ITS 2018 CAPITAL SPENDING WILL BE APPROXIMATELY $150 MILLION​ * FOR FULL-YEAR 2017, INCOME TAX EXPENSE WAS $80.9 MILLION, WHICH REPRESENTED AN EFFECTIVE TAX RATE OF 36.4% * Q4 EARNINGS PER SHARE VIEW $0.63, REVENUE VIEW $416.6 MILLION -- THOMSON REUTERS I/B/E/S * FY2018 EARNINGS PER SHARE VIEW $2.90, REVENUE VIEW $1.73 BILLION -- THOMSON REUTERS I/B/E/S * WEST PHARMACEUTICAL SERVICES - EXPECT RESTRUCTURING WILL PROVIDE CO WITH ANNUALIZED SAVINGS OF $17.0 MILLION TO $22.0 MILLION Source text for Eikon:  ", "external_links": [], "published": "2018-02-15T13:15:00.000+02:00", "crawled": "2018-02-15T13:38:45.013+02:00", "highlightTitle": ""}